The Future of Healthcare is here: Advet Bhambhani’s Luxury Vision

This health revolution in the Middle East and India is spearheaded by Advet Bhambhani. As the founder and chairman of Advet Bhambhani Ventures (ABV), he envisions boutique medical experiences for patients that could be extremely luxurious, never seen before. Starting with the UAE’s very first mobile health care service, to planning chain hospitals for luxury under the umbrella of Nucleus Hospitals, Bhambhani has etched his mark as a pioneering entrepreneur to revolutionize health care norms with diversifications in all sectors he steps into.

The recent business venture, Nucleus Hospitals, under ABV is expected to reshape health care in its modernized sense. His plan to establish the first luxury hospital chain for the Middle East and India focuses on integrating cutting-edge medical technologies with a personal, boutique experience. He plans to open five boutique hospitals by 2020 in key locations in the Gulf and India to cater to patients who appreciate comfort, exclusivity, and top-tier healthcare services in one seamless package.

Nucleus Hospitals claims to bring the experience of luxury hotels in the delivery of healthcare services with state-of-the-art facilities, high-class interior design, and high specialty care. The focus here is not just on the elite class but on the increasing trend of experiencing more in terms of the patient experience in the region.

ABV is no stranger to high ambition. The flagship holding company for the UAE health sector is already dominated by Lifeline Healthcare. With nine medical centers, three hospitals, and a fleet of private ambulances, Lifeline Healthcare is a trusted name in the industry. In addition to traditional healthcare services, the group operates mobile healthcare units—the first of their kind in the UAE—and telemedicine platforms like 800 Doctor, further pushing boundaries in accessible healthcare. Bhambhani’s vision extends beyond the UAE to Oman, Qatar, and the broader Gulf Cooperation Council (GCC) region. These expansion plans reflect his belief in providing great healthcare to the underserved regions and pioneering advancements, which set benchmarks for this industry.

Under Bhambhani, the company has grown into a 300 million dollar company with 500 employees and is shaping the health and wellness sector with its strength. This is due to his entrepreneurial spirit, strategic planning to stay ahead of market needs, and staying in trend. ABV ventures deal not only with patients but also with pharmaceutical and medical supply through ION Pharmacies, which reflects a healthy approach to healthcare.

Bhambhani is an innovative and adaptable leader who has positioned his company as a key player in the rapidly evolving healthcare market of the Middle East.

While his core businesses center on health care, he has diversified into other spaces also. He serves as the executive director of Constellation – the Dubai-based theatrical events company. His foraying in the entertainment world ascertains the fact that a person like Bhambhani can look at opportunities out and beyond the core that sets him up as someone all-rounded in entrepreneurship.

Constellation has been pivotal in bringing world-class theatrical performances and cultural events to the city of Dubai, further enriching its vibrant arts scene. The dual focus on healthcare and entertainment by Bhambhani represents a rather unique approach to entrepreneurship through innovation combined with creativity.

With plans for boutique hospitals, regional expansions, and a continued focus on enhancing patient care, Advet Bhambhani Ventures is poised for sustained growth. Bhambhani’s holistic vision includes integrating advanced technologies like AI-driven healthcare platforms and fostering community-focused initiatives. His approach emphasizes not just building infrastructure but also improving overall patient experiences and outcomes.

By giving the same importance to innovation, quality, and accessibility, Bhambhani ensures that his ventures leave a long-lasting impact in both patients and the healthcare industry as a whole.